Afrezza

Why MannKind Stock Crushed it Monday
Why MannKind Stock Crushed it Monday
Motley Fool
MannKind
ADA
diabetes
insulin
Afrezza
inhaled insulin
Flag link:
Why MannKind Is Up Big Today
Why MannKind Is Up Big Today
Motley Fool
MannKind
inhaled insulin
Afrezza
Flag link:
MannKind (MNKD) Q4 Revenues Rise 254%; Achieves First Ever Qtr Afrezza Gross Profit
MannKind (MNKD) Q4 Revenues Rise 254%; Achieves First Ever Qtr Afrezza Gross Profit
Street Insider
MannKind
earnings
Afrezza
Flag link:
FDA’s OPDP Warns MannKind for Facebook Post
FDA’s OPDP Warns MannKind for Facebook Post
RAPS.org
Afrezza
warning letter
FDA
OPDP
Facebook
social media
diabetes
MannKind
Flag link:
Can MannKind Corporation Avert Bankruptcy?
Can MannKind Corporation Avert Bankruptcy?
Motley Fool
MannKind
earnings
Afrezza
Flag link:
Why MannKind Corporation Stock Is Falling Back to Earth Today
Why MannKind Corporation Stock Is Falling Back to Earth Today
Motley Fool
MannKind
diabetes
Afrezza
Flag link:
Why MannKind Corporation Jumped Higher Today
Why MannKind Corporation Jumped Higher Today
Motley Fool
MannKind
diabetes
Afrezza
Flag link:
3 Drug Stocks That Soared This Week
3 Drug Stocks That Soared This Week
Motley Fool
Endocyte
PSMA-617
MannKind
Afrezza
Mylan Labs
generics
Teva Pharmaceutical
Flag link:
FDA approves new label language for Afrezza
FDA approves new label language for Afrezza
Greenwich Citizen, CT
FDA
labeling
Afrezza
inhaled insulin
MannKind
diabetes
Flag link:
Why MannKind Stock Started October With a Bang
Why MannKind Stock Started October With a Bang
Motley Fool
MannKind
inhaled insulin
Afrezza
diabetes
Flag link:
MannKind - Afrezza Scripts Finish August Flat
MannKind - Afrezza Scripts Finish August Flat
Seeking Alpha
MannKind
Afrezza
diabetes
inhaled insulin
Flag link:
MannKind combines inhaled insulin with One Drop’s digital diabetes tech
MannKind combines inhaled insulin with One Drop’s digital diabetes tech
Drug Delivery Business News
MannKind
inhaled insulin
One Drop
Afrezza
Flag link:
MannKind: Afrezza Television Ad Debuts; What Investors Need To Know
MannKind: Afrezza Television Ad Debuts; What Investors Need To Know
Seeking Alpha
MannKind
Afrezza
drug ads
diabetes
investors
inhaled insulin
Flag link:
MannKind - Afrezza Scripts Come Back Down After ADA Conference Bump
MannKind - Afrezza Scripts Come Back Down After ADA Conference Bump
Seeking Alpha
Afrezza
MannKind
diabetes
inhaled insulin
Flag link:
MannKind: Afrezza Sales See Best Result In More Than A Year
MannKind: Afrezza Sales See Best Result In More Than A Year
Seeking Alpha
MannKind
Afrezza
diabetes
inhaled insulin
Flag link:
MannKind’s Afrezza needs a big turn. Can reality TV and a new commercial get it done?
MannKind’s Afrezza needs a big turn. Can reality TV and a new commercial get it done?
Fierce Pharma
MannKind
Afrezza
diabetes
television ads
drug marketing
Flag link:
MannKind Scripts Not Helping Cash Situation
MannKind Scripts Not Helping Cash Situation
Seeking Alpha
MannKind
Afrezza
diabetes
inhaled insulin
Flag link:
MannKind inks deal to bring inhaled insulin to Brazil
MannKind inks deal to bring inhaled insulin to Brazil
Drug Delivery Business News
MannKind
Brazil
diabetes
inhaled insulin
Afrezza
Flag link:
One Drop, MannKind ink partnership for connected, inhaled diabetes tech
One Drop, MannKind ink partnership for connected, inhaled diabetes tech
Drug Delivery Business News
One Drop
MannKind
inhaled insulin
diabetes
devices
Afrezza
Flag link:
MannKind: Afrezza Sales Remain Low As Q1 Comes To A Close
MannKind: Afrezza Sales Remain Low As Q1 Comes To A Close
Seeking Alpha
MannKind
Afrezza
inhaled insulin
diabetes
Flag link:

Pages